Company / Working Capital
NOVAVAX INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$518.3M
FY2025
5-year range
-$756.6M / $518.3M
FY2021-FY2025
Trend
+2134.7%
vs FY2024
Sector context
#88 of 213
Health Care
What the data says
Working Capital changed +2135% YoY in FY2025, a notable deviation from the 9-year average annual change of +295%.
Based on SEC 10-K filings.
$518M in FY2025 with a 5-year CAGR of -5.0%.
Improved from -$491M to $518M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
#88 of 213 in Health CareTop 41% of 213This company $518.3M Sector average $934.6M
▼
-44.5% below sector average
Key checks
Key Insights
- NOVAVAX INC's working capital has grown for 3 consecutive years.
- 5-year CAGR of -5.0%, indicating a declining trend.
- In FY2025, working capital increased 2134.7% year-over-year.
- Ranks #88 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $518.3M | +2134.7% |
| FY2024 | -$25.5M | +94.8% |
| FY2023 | -$491.3M | +35.1% |
| FY2022 | -$756.6M | -221.7% |
| FY2021 | -$235.2M | -135.2% |
| FY2020 | $668.5M | +835.6% |
| FY2019 | $71.5M | -3.1% |
| FY2018 | $73.7M | -43.1% |
| FY2017 | $129.6M | -41.5% |
| FY2016 | $221.4M | +5.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026